![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/12/22/2800400/0/en/Polaris-Group-Announced-the-Acquisition-of-Genovior-Biotech-Initiating-Dual-Engine-Growth.html
https://www.globenewswire.com//news-release/2023/12/04/2789883/0/en/Polaris-Group-Initiates-Phase-3-Trial-First-Patient-Successfully-Dosed-with-ADI-PEG-20-Placebo-plus-Gemcitabine-and-Docetaxel-for-Difficult-to-Treat-Leiomyosarcoma-LMS.html
https://www.globenewswire.com//news-release/2023/11/30/2788176/0/en/Polaris-Group-Announces-First-Patient-Successfully-Dosed-with-ADI-PEG-20-Placebo-in-Phase-2a-Non-Alcoholic-Steatohepatitis-NASH-Study.html
https://www.globenewswire.com//news-release/2023/11/17/2782330/0/en/Polaris-Group-Initiates-Rolling-Submission-of-Biologic-License-Application-BLA-for-ADI-PEG-20-with-U-S-FDA-to-Treat-Malignant-Pleural-Mesothelioma.html